Safety and Preliminary Clinical Outcomes of Integrating Engineered Synthetic Lipid Vesicles (Biosomes) in a Skin Booster Protocol: A Prospective Observational Study

Background

Engineered synthetic lipid vesicles with biomimetic architecture have emerged as promising adjunctive agents in aesthetic medicine. Nevertheless, objective evidence evaluating their integration within standardized, minimally invasive skin booster protocols remains limited. The study aimed to assess the safety, tolerability, and preliminary clinical outcomes of incorporating engineered synthetic lipid vesicles (Biosomes) into a facial skin booster protocol.